The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(4-Amino-3-methyl-phenyl)-8-(3-bromo-4,5-dihydro-isoxazol-5-ylmethyl)-2,3,8,10-tetrahydro-1,4-dioxa-7,8-diaza-cyclohepta[b]naphthalen-9-one ID: ALA4088629
PubChem CID: 137643689
Max Phase: Preclinical
Molecular Formula: C22H21BrN4O4
Molecular Weight: 485.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C2=NN(CC3CC(Br)=NO3)C(=O)Cc3cc4c(cc32)OCCO4)ccc1N
Standard InChI: InChI=1S/C22H21BrN4O4/c1-12-6-13(2-3-17(12)24)22-16-10-19-18(29-4-5-30-19)7-14(16)8-21(28)27(25-22)11-15-9-20(23)26-31-15/h2-3,6-7,10,15H,4-5,8-9,11,24H2,1H3
Standard InChI Key: YYXVQJJRUFHQSF-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 35 0 0 0 0 0 0 0 0999 V2000
23.4985 -20.2933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4967 -18.6404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2131 -19.8758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2120 -19.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8601 -18.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8655 -20.3922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6697 -18.7053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6753 -20.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0303 -19.4518 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.6854 -21.1972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8989 -21.4414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7186 -22.2457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3260 -22.8052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1165 -22.5548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2931 -21.7512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1469 -23.6105 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.1810 -18.0579 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.7854 -19.8784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7803 -19.0562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0698 -18.6517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.3596 -19.0649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3646 -19.8872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0799 -20.2962 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8566 -19.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2760 -20.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9498 -20.9091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.5682 -21.4552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2786 -21.0358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0992 -20.2306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0355 -21.3640 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
25.7257 -23.1113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18 1 1 0
1 3 2 0
4 2 2 0
2 19 1 0
3 4 1 0
4 5 1 0
3 6 1 0
5 7 1 0
6 8 2 0
7 9 1 0
8 9 1 0
6 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
13 16 1 0
7 17 2 0
18 19 2 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
9 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 25 1 0
28 30 1 0
14 31 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 485.34Molecular Weight (Monoisotopic): 484.0746AlogP: 2.98#Rotatable Bonds: 3Polar Surface Area: 98.74Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.17CX LogP: 2.81CX LogD: 2.81Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.67Np Likeness Score: -0.42
References 1. Espahbodinia M, Ettari R, Wen W, Wu A, Shen YC, Niu L, Grasso S, Zappalà M.. (2017) Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists., 25 (14): [PMID:28571973 ] [10.1016/j.bmc.2017.05.036 ]